Opexa Therapeutics CEO Chris Schelling's 2019 pay jumps 167% to $1.5M
Opexa Therapeutics reports 2019 executive compensation
By ExecPay News
Published: October 14, 2020
Opexa Therapeutics reported fiscal year 2019 executive compensation information on October 14, 2020.
In 2019, three executives at Opexa Therapeutics received on average a compensation package of $1.1M, a 129% increase compared to previous year.
Chris Schelling, Chief Executive Officer, received $1.5M in total, which increased by 167% compared to 2018. 70.28% of Schelling's compensation, or $1M, was in option awards. Schelling also received $436K in salary.
William T. Andrews, M.D., FACP, Chief Medical Officer, received a compensation package of $1.1M, which increased by 115% compared to previous year. 42.53% of the compensation package, or $462K, was in option awards.
Harry Palmin, Chief Financial Officer, earned $844.4K in 2019, a 97% increase compared to previous year.